{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T04:00:50Z","timestamp":1780977650088,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.msard.2026.107274","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:42:16Z","timestamp":1779583336000},"page":"107274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Building sustainable multiple sclerosis registries in Latin America: A practical framework for real-world evidence generation and healthcare access"],"prefix":"10.1016","volume":"111","author":[{"given":"Juan I.","family":"Rojas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Patrucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo","family":"Cristiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jefferson","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego H.","family":"Giunta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107274_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103483","article-title":"Evaluation of the times of disability progression and related factors in patients with primary progressive multiple sclerosis from Argentina","volume":"58","author":"Alonso","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2026.107274_bib0002","article-title":"Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies","volume":"9","author":"Alonso","year":"2023","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2026.107274_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104935","article-title":"Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in Argentina","volume":"79","author":"Alonso","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.msard.2026.107274_bib0005","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ejvs.2022.08.011","article-title":"A Delphi consensus on patient reported outcomes for registries and trials including patients with intermittent claudication: recommendations and reporting standard","volume":"64","author":"Arndt","year":"2022","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"4","key":"10.1016\/j.msard.2026.107274_bib0006","article-title":"Mortality of neuromyelitis optica spectrum disorder patients in an Argentinean population: a study from the RelevarEM registry","volume":"9","author":"Carnero Contentti","year":"2023","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"issue":"10","key":"10.1016\/j.msard.2026.107274_bib0007","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1177\/13524585231187120","article-title":"Frequency of new asymptomatic MRI lesions during attacks and follow-up of patients with NMOSD in a real-world setting","volume":"29","author":"Carnero Contentti","year":"2023","journal-title":"Mult. Scler."},{"issue":"7","key":"10.1016\/j.msard.2026.107274_bib0008","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/bioe.13438","article-title":"The ethics of informed consent for data registries: moving beyond moral minimalism to the high ground","volume":"39","author":"Chingarande","year":"2025","journal-title":"Bioethics"},{"issue":"12","key":"10.1016\/j.msard.2026.107274_bib0009","first-page":"1","article-title":"Epidemiology and healthcare access in Brazilian multiple sclerosis patients: insights from the BRANDO database","volume":"83","author":"Damasceno","year":"2025","journal-title":"Arq. Neuropsiquiatr."},{"issue":"1","key":"10.1016\/j.msard.2026.107274_bib0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11739-022-03151-1","article-title":"Registries of rare diseases: current knowledge and future perspectives","volume":"18","author":"Gelain","year":"2023","journal-title":"Intern Emerg Med."},{"issue":"2","key":"10.1016\/j.msard.2026.107274_bib0011","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/01616412.2022.2124792","article-title":"Disease activity after discontinuation of disease-modifying therapies in patients with multiple sclerosis in Argentina: data from the nationwide registry RelevarEM","volume":"45","author":"Gisela","year":"2023","journal-title":"Neurol. Res."},{"key":"10.1016\/j.msard.2026.107274_bib0001","doi-asserted-by":"crossref","unstructured":"Gliklich RE, Leavy MB, Dreyer NA, editors. Registries for Evaluating Patient Outcomes: A User\u2019s Guide. 4th ed. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020. 2020.","DOI":"10.23970\/AHRQEPCREGISTRIES4"},{"issue":"13","key":"10.1016\/j.msard.2026.107274_bib0012","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1177\/1352458516653667","article-title":"Observational data: understanding the real MS world","volume":"22","author":"Kalincik","year":"2016","journal-title":"Mult. Scler."},{"issue":"Pt 11","key":"10.1016\/j.msard.2026.107274_bib0013","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1093\/brain\/awv258","article-title":"Defining reliable disability outcomes in multiple sclerosis","volume":"138","author":"Kalincik","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.msard.2026.107274_bib0014","article-title":"The creation of an adaptable informed consent form for research purposes to overcome national and institutional bottlenecks in ethics review: experience from rare disease registries","volume":"11","author":"Landi","year":"2024","journal-title":"Front. Med. (Lausanne)"},{"issue":"4","key":"10.1016\/j.msard.2026.107274_bib0015","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/1740774520905576","article-title":"Regulatory-grade clinical trial design using real-world data","volume":"17","author":"Levenson","year":"2020","journal-title":"Clin. Trials"},{"issue":"7","key":"10.1016\/j.msard.2026.107274_bib0016","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jval.2017.03.008","article-title":"What is real-world data? A review of definitions based on literature and stakeholder interviews","volume":"20","author":"Makady","year":"2017","journal-title":"Value Health."},{"key":"10.1016\/j.msard.2026.107274_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.jisako.2025.100911","article-title":"From data to decisions: the evolution and impact of hip preservation registries","volume":"12","author":"McWilliams","year":"2025","journal-title":"J. ISAKOS"},{"issue":"1","key":"10.1016\/j.msard.2026.107274_bib0018","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jval.2014.10.008","article-title":"Evaluation of patient registries supporting reimbursement decisions: the case of oxaliplatin for treatment of stage III colon cancer","volume":"18","author":"Mohseninejad","year":"2015","journal-title":"Value Health."},{"issue":"3","key":"10.1016\/j.msard.2026.107274_bib0019","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/13524585231216004","article-title":"Introducing a core dataset for real-world data in multiple sclerosis registries and cohorts: recommendations from a global task force","volume":"30","author":"Parciak","year":"2024","journal-title":"Mult. Scler."},{"issue":"10","key":"10.1016\/j.msard.2026.107274_bib0020","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1177\/1352458520941485","article-title":"COVID-19 in people with multiple sclerosis: a global data sharing initiative","volume":"26","author":"Peeters","year":"2020","journal-title":"Mult. Scler."},{"issue":"4\u20135","key":"10.1016\/j.msard.2026.107274_bib0021","first-page":"361","article-title":"[Registers as central real world data source: the experience of the Italian multiple sclerosis and related disorders register]","volume":"48","author":"Ponzio","year":"2024","journal-title":"Epidemiol. Prev."},{"issue":"6","key":"10.1016\/j.msard.2026.107274_bib0022","article-title":"[Future of registries]","volume":"72","author":"Range","year":"2023","journal-title":"Ann. Cardiol Angeiol. (Paris)"},{"key":"10.1016\/j.msard.2026.107274_bib0027","article-title":"Multiple sclerosis in Latin America: a different disease course severity? A collaborative study from the MSBase Registry","volume":"1","author":"Rojas","year":"2015","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2026.107274_bib0024","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.msard.2019.05.004","article-title":"The Argentinean multiple sclerosis registry (RelevarEM): methodological aspects and directions","volume":"32","author":"Rojas","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.msard.2026.107274_bib0023","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s10072-019-04230-6","article-title":"Multiple sclerosis and neuromyelitis optica spectrum disorders in Argentina: comparing baseline data from the Argentinean MS registry (RelevarEM)","volume":"41","author":"Rojas","year":"2020","journal-title":"Neurol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2026.107274_bib0026","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10072-022-06409-w","article-title":"Disability outcomes in NMOSD and MOGAD patients: data from a nationwide registry in Argentina","volume":"44","author":"Rojas","year":"2023","journal-title":"Neurol. Sci."},{"issue":"7","key":"10.1016\/j.msard.2026.107274_bib0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.33588\/rn.7807.2023326","article-title":"[Core data set for real world data in multiple sclerosis: customization for Latin America from a global task force recommendation]","volume":"78","author":"Rojas","year":"2024","journal-title":"Rev. Neurol."},{"issue":"23","key":"10.1016\/j.msard.2026.107274_bib0028","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","article-title":"Real-world evidence - what is it and what can it tell us?","volume":"375","author":"Sherman","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.msard.2026.107274_bib0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrneurol.2016.188","article-title":"Treatment decisions in multiple sclerosis - insights from real-world observational studies","volume":"13","author":"Trojano","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"12","key":"10.1016\/j.msard.2026.107274_bib0029","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s00415-025-13439-9","article-title":"Big multiple sclerosis data network: novel modelling approaches for real-world data analysis","volume":"272","author":"Trojano","year":"2025","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2026.107274_bib0031","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1186\/s12916-024-03799-w","article-title":"Ethics practices associated with reusing health data: an assessment of patient registries","volume":"22","author":"van den Akker","year":"2024","journal-title":"BMC Med."},{"issue":"1","key":"10.1016\/j.msard.2026.107274_bib0032","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12265-024-10563-1","article-title":"Past trends and future directions of Cardiac regenerative medicine - A systematic analysis of clinical trial registries","volume":"18","author":"Wulfse","year":"2025","journal-title":"J. Cardiovasc. Transl. Res."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482600310X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221103482600310X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T03:37:47Z","timestamp":1780976267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221103482600310X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":32,"alternative-id":["S221103482600310X"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107274","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Building sustainable multiple sclerosis registries in Latin America: A practical framework for real-world evidence generation and healthcare access","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107274","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107274"}}